| pubmed-article:3834064 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C0019944 | lld:lifeskim |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C0031463 | lld:lifeskim |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C0109354 | lld:lifeskim |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C0743223 | lld:lifeskim |
| pubmed-article:3834064 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:3834064 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:3834064 | pubmed:dateCreated | 1986-6-2 | lld:pubmed |
| pubmed-article:3834064 | pubmed:abstractText | The effects of i.v. chloramphenicol sodium succinate on the pharmacokinetics of i.v. phenylbutazone in six healthy adult horses were investigated. Administration of chloramphenicol sodium succinate to mares reduced mean (+/- SD) phenylbutazone clearance from 0.600 +/- 0.222 to 0.339 +/- 0.123 ml/min per kg and increased mean (+/- SD) half life from 244 +/- 59.8 to 371 +/- 80.8 min and mean residence time from 333 +/- 86.2 to 533 +/- 124 min. The mean steady-state volume of distribution of phenylbutazone was unchanged, with mean (+/- SD) values of 187 +/- 28.9 ml/kg in control animals and 170 +/- 32.4 ml/kg after chloramphenicol sodium succinate. | lld:pubmed |
| pubmed-article:3834064 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3834064 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3834064 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3834064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3834064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3834064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3834064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3834064 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3834064 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:3834064 | pubmed:issn | 0090-466X | lld:pubmed |
| pubmed-article:3834064 | pubmed:author | pubmed-author:SethV KVK | lld:pubmed |
| pubmed-article:3834064 | pubmed:author | pubmed-author:GerkenD FDF | lld:pubmed |
| pubmed-article:3834064 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3834064 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:3834064 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3834064 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3834064 | pubmed:pagination | 467-76 | lld:pubmed |
| pubmed-article:3834064 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:meshHeading | pubmed-meshheading:3834064-... | lld:pubmed |
| pubmed-article:3834064 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3834064 | pubmed:articleTitle | Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses. | lld:pubmed |
| pubmed-article:3834064 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3834064 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
